(17314506), R. L., (17314509), E. M., (17314512), A. L., (17314515), N. G., (17314518), I. C., (17314521), A. A., . . . (17314731), D. V. (2025). Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Chicago Style (17. basım) Atıf(17314506), Raphaël Leman, et al. Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.
MLA (9th ed.) Atıf(17314506), Raphaël Leman, et al. Supplementary Table S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.